Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab

INTRODUCTION: Patients with multiple myeloma (MM) frequently reported immune impairment with an increased risk for infection-related mortality. We aimed to evaluate the immune response in MM patients vaccinated for SARS-CoV-2 during active treatment. METHODS: We enrolled 158 patients affected by act...

Descripción completa

Detalles Bibliográficos
Autores principales: Duminuco, Andrea, Romano, Alessandra, Leotta, Dario, La Spina, Enrico, Cambria, Daniela, Bulla, Anna, Del Fabro, Vittorio, Tibullo, Daniele, Giallongo, Cesarina, Palumbo, Giuseppe A., Conticello, Concetta, Di Raimondo, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090508/
https://www.ncbi.nlm.nih.gov/pubmed/37064138
http://dx.doi.org/10.3389/fonc.2023.1157610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090508/
https://www.ncbi.nlm.nih.gov/pubmed/37064138
http://dx.doi.org/10.3389/fonc.2023.1157610

Ejemplares similares